Photo of Guillaume Julian

Guillaume Julian

Guillaume Julian is an associate in the firm’s Washington, DC office, where he is a member of the Food, Drug, and Device and Health Care Practice Groups. He advises pharmaceutical, biotechnology, medical device, and food companies on a variety of regulatory and compliance issues.

Contact:Read more about Guillaume JulianEmail

On September 9, 2025, the Department of Health and Human Services (“HHS”) and Food and Drug Administration (“FDA”) announced a series of measures to address “misleading” direct-to-consumer prescription drug (“DTC”) advertisements. The measures include (1) rulemaking to rescind the “adequate provision” requirement, which permits manufacturers to include a general statement…

Continue Reading FDA and HHS Announce New Measures to Curb Direct-to-Consumer Prescription Drug Advertising